SWKH News and Press, SWK Holdings Corporation From 09/15/20

DALLAS , Sept. 15, 2020 /PRNewswire/ --  SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its chairman and chief executive officer, Winston Black , will present at two upcoming investor conferences. Details of SWK Hol...

BOONTON, N.J. , Sept. 15, 2020 /PRNewswire/ --  Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced that the compan...

Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.com NEW YORK, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and ind...

BOONTON, N.J. , Sept. 9, 2020 /PRNewswire/ --  Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced that the company...

DALLAS , Sept. 9, 2020 /PRNewswire/ --  SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its chairman and chief executive officer, Winston Black , will participate in the 2020 Colliers Institutional Investor Conference,...

INCLINE VILLAGE, Nev. , Aug. 31, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces the signing and closing of a definitive agreement for the sale of three royalty interests for Kybella ® , Zalviso ® , and Coflex ® (collectively...

SWK Holdings Corporation (SWKH) Q2 2020 Results Conference Call August 17, 2020 10:00 AM ET Company Participants Jason Rando - Tiberend Strategic Advisors Winston Black - Chairman and CEO Conference Call Participants Kyle Bauser - Colliers Securities Nat Stewart - N.A.S...

SWK Holdings (NASDAQ: SWKH ) : Q2 GAAP EPS of $0.07 beats by $0.14 . More news on: SWK Holdings Corporation, Earnings news and commentary, Financial stocks news, , Read more ...

DALLAS , Aug. 17, 2020 /PRNewswire/ -- Corporate Highlights Rajiv Khosla , Ph.D. appointed as Chief Executive Officer of Enteris BioPharma Repurchased $1.0 million of common stock during the three-month span ended June 30, 2020 SWK Holdings Added to Russell 3000™, 2...

DALLAS , Aug. 14, 2020 /PRNewswire/ --  SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, announced that the Company will host a conference call and live audio webcast on Monday, August 17, 2020 , at 10:00 a.m. ET , to discuss its corporate...